Single User License
INR 8059
Site License
INR 16118
Corporate User License
INR 24176

Service Tax Additional

select a format
Price

Single User License
USD 125
Site License
USD 250
Corporate User License
USD 375

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Merrimack Pharmaceuticals Inc (MACK)-Financial and Strategic SWOT Analysis Review

Merrimack Pharmaceuticals Inc (MACK)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH136492FSA
  • |
  • Pages: 49
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Merrimack Pharmaceuticals Inc (MACK)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merrimack Pharmaceuticals Inc (Merrimack) is a biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of various types of cancers. The company's marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (marketed chemotherapy drug) in a liposomal formulation used in the treatment of pancreatic metastatic adenocarcinoma. Its pipeline portfolio includes investigational candidates targeted at the treatment of advanced non-small cell lung cancer (NSCLC), solid tumors, metastatic breast cancer, and heregulin positive breast cancer. The company sells its products through a network of distributors in the US. Merrimack is headquartered in Cambridge, Massachusetts, the US.

Merrimack Pharmaceuticals Inc Key Recent Developments

May 25,2017: Merrimack Announces Management Change

May 10,2017: Merrimack Reports First Quarter 2017 Financial Results

Mar 01,2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results

Jan 18,2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO

Nov 09,2016: Merrimack Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Merrimack Pharmaceuticals Inc-Key Facts 6

Merrimack Pharmaceuticals Inc-Key Employees 7

Merrimack Pharmaceuticals Inc-Key Employee Biographies 8

Merrimack Pharmaceuticals Inc-Major Products and Services 9

Merrimack Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 10

Merrimack Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Merrimack Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Merrimack Pharmaceuticals Inc-History 12

Merrimack Pharmaceuticals Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Merrimack Pharmaceuticals Inc-Business Description 14

Merrimack Pharmaceuticals Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Merrimack Pharmaceuticals Inc-Strengths 15

Merrimack Pharmaceuticals Inc-Weaknesses 16

Merrimack Pharmaceuticals Inc-Opportunities 17

Merrimack Pharmaceuticals Inc-Threats 18

Merrimack Pharmaceuticals Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Merrimack Pharmaceuticals Inc, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

May 25, 2017: Merrimack Announces Management Change 29

May 10, 2017: Merrimack Reports First Quarter 2017 Financial Results 30

Mar 01, 2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results 32

Jan 18, 2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO 34

Nov 09, 2016: Merrimack Reports Third Quarter 2016 Financial Results 35

Oct 03, 2016: Merrimack Announces Major Corporate Restructuring 37

Aug 04, 2016: Merrimack Reports Second Quarter 2016 Financial Results 38

May 18, 2016: Merrimack to Present on Extensive Oncology Pipeline at the 2016 American Society of Clinical Oncology Annual Meeting 40

May 02, 2016: Merrimack Reports First Quarter 2016 Financial Results 42

Mar 16, 2016: Merrimack to Present on Multiple Oncology Programs at the 2016 American Association for Cancer Research Annual Meeting 43

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Figures

Merrimack Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Merrimack Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Merrimack Pharmaceuticals Inc, Performance Chart (2012-2016) 23

Merrimack Pharmaceuticals Inc, Ratio Charts 25

Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

List of Tables

Merrimack Pharmaceuticals Inc, Key Facts 6

Merrimack Pharmaceuticals Inc, Key Employees 7

Merrimack Pharmaceuticals Inc, Key Employee Biographies 8

Merrimack Pharmaceuticals Inc, Major Products and Services 9

Merrimack Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 10

Merrimack Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 11

Merrimack Pharmaceuticals Inc, History 12

Merrimack Pharmaceuticals Inc, Subsidiaries 13

Merrimack Pharmaceuticals Inc, Key Competitors 19

Merrimack Pharmaceuticals Inc, Ratios based on current share price 20

Merrimack Pharmaceuticals Inc, Annual Ratios 21

Merrimack Pharmaceuticals Inc, Annual Ratios (Cont...1) 22

Merrimack Pharmaceuticals Inc, Interim Ratios 24

Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Merrimack Pharmaceuticals Inc, Recent Deals Summary 28

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Merrimack Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com